Gilead Sciences

Summary

This biopharmaceutical company focuses on developing innovative medicines to address significant public health challenges, particularly in the areas of HIV, liver disease, cancer, and inflammation. It has a strong commitment to research and development, with a diverse pipeline of clinical programs aimed at improving health outcomes globally. The company also emphasizes health equity and access to medicines, particularly in resource-limited settings.